Profile avatar
ysioscapital.bsky.social
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide. Sign up & stay tuned http://eepurl.com/duXVDv 📩
21 posts 49 followers 76 following
Regular Contributor
Posts 22 Comments 0

#PortfolioNews | Adcendo receives #FDA clearance for Phase I trial of ADCE-T02 🎯 First-in-class #ADC targeting Tissue Factor in #SolidTumors. 🌍 Now recruiting in #Australia with #US expansion soon! 👉 Read more https://buff.ly/3Dc92qj #Onclogy #vc

submitted 5 days ago • 0 comments

#PortfolioNews | Our #portfolio company Neurona Therapeutics plans Phase3 trial in H2 2025 for NRTX-1001, a #celltherapy for drug-resistant #epilepsy. 🔬 Encouraging early data: Up to 97% seizure reduction with no cognitive impairment 📢 Read more: https://buff.ly/3Dh9kfv #VC

submitted 7 days ago • 0 comments

#Speaker I Our Managing Partner, Karen Wagner, will join the Early-Stage Investment Panel at #Sachs_ELSF! 📅 Feb 27 | ⏰ 14:05 💡 Insights on #BiotechInvestment, #VC, & #funding strategies for startups. 👉 Details: https://buff.ly/4hSfnGt #EarlyStageFunding #LifeSciencesVC

submitted 8 days ago • 0 comments

#PortfolioNews I NorthSea Therapeutics strengthens leadership & advances metabolic, cholestatic & fibrotic disease therapies. 🔬 Key trials ahead! 👉 https://buff.ly/3Quv4HV #vc #MetabolicDiseases

submitted 10 days ago • 0 comments

#PortfolioNews I Our #portfolio company ONA Therapeutics strengthens leadership to accelerate first-in-class #ADCs targeting resistant #cancer cells & advancing toward #clinical development. 📢 Read more here https://buff.ly/4gK9vh3 #Oncology #Biotech #Pharma #YsiosPortfolio

submitted 12 days ago • 0 comments

📈¿Cómo generar #impacto y #rentabilidad en #ciencia y #tecnología? 💡 Descúbrelo en la mesa redonda "Retos para inversores" con nuestro #Partner Raúl Martín-Ruiz. 📅 20 FEB | ⏰ 13:40h | 📍 Auditorio ABANCA 🔗Programa👉https://buff.ly/4k83b5V #InvertirEnCienciaSíEsRentable

submitted 13 days ago • 0 comments

🚀 Join us live for the #BIOSPAIN2025 presentation! 🔬 #Innovation, #investment & #biotech insights, get a first look at what's coming! 💡 Panel with industry voices incl. Guillem Laporta, Partner at Ysios Capital 🔴Live at 10:00 👉 https://buff.ly/4hKlSeC 📅 Full program 👉 https://buff.ly/3QmbfT2

submitted 14 days ago • 0 comments

🚀Curious about #Entrepreneurship & #VentureCapital in #LifeSciences? Join Laura Argelich, Analyst at @ysioscapital.bsky.social, at "Bridges to Industry" to learn from top investors! @irbbarcelona.org 📅 Feb 20 |@www.pcb.ub.edu ⏳ Deadline Feb 13! buff.ly/3CBWRTA #BCNHealthInnovationWeek #WomenInVC

submitted 20 days ago • 0 comments

#Speaker I Our #Partner Raúl Martín-Ruiz will speak at #BioNeuroscience Congress 🧠 🗓️ Feb 26 ⏰ 12:15 💡 Leading Early-Stage Neuroscience Investors. What CEOs Need To Know 🔥 Don’t miss this top #VC panel on #CNS & #Biotech! 👉 Details: www.broadreach-global.com/bio-neurosci...

submitted 21 days ago • 0 comments

#congress I Nos vemos esta semana en el #AcexHealth #InvestorDay organizado por Fundacion PTS ! 🙋‍♂️🧳 Guillem Laporta 👉https://buff.ly/413vACQ 🗓️11 Febrero, 2025 📍Granada #vc #Spain #Innovación #Salud

submitted 22 days ago • 0 comments

🎙️Nueva entrega de nuestro #Podcast! PÍLDORAS DE BIOTECH💊 🎯 𝗝.𝗣. 𝗠𝗼𝗿𝗴𝗮𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 📈 Descubre los acuerdos, #tendencias y #retos que marcarán el 2025 en #pharma y #biotech. ▶️ https://buff.ly/3Q5lgnn #YsiosPodcast #BiotechPillsWithJordi

submitted 27 days ago • 0 comments

#PortfolioNews I Our #quoted #portfolio company #Mineralys #MLYS completed Enrollment in Explore-CKD Phase 2 Trial of #Lorundrostat for the Treatment of #Hypertension in Subjects with Stage 2 to 3b chronic kidney disease #CKD and #Albuminuria 👉 https://buff.ly/4gqM4t2 #vc #ClinicalTrials

submitted 27 days ago • 0 comments

#congress I See you this week at #BioCapitalEurope2025 by EQT Life Sciences! 🙋‍♂️🧳 Guillem Laporta 👉 https://buff.ly/4aI0G5X 📅 5 - 6 February , 2025 📍 Amsterdam

submitted 29 days ago • 0 comments

#entrevista I🔬#TelescopeBiotechFund , una apuesta estratégica por la #biotecnología cotizada. Descúbrelo con @jordixiol.bsky.social , Partner en @ysioscapital.bsky.social y Horacio Encabo de Andbank en @capitalradiob.bsky.social ▶️ https://buff.ly/3CkLQG7 #FondosDeInversión #MercadoFinanciero

submitted 32 days ago • 0 comments

📢Nos alegra anunciar el lanzamiento de 𝗧𝗲𝗹𝗲𝘀𝗰𝗼𝗽𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗙𝘂𝗻𝗱, gestionado por Andbank , que contará con nuestro asesoramiento especializado. 🎯Fondo con vocación global que invertirá en compañías cotizadas del sector biomédico, principalmente en #Nasdaq y #NYSE 👉 bit.ly/3ZXE8ue #fund

submitted 75 days ago • 0 comments

🌍At Ysios Capital, we’re committed to driving positive change in the #LifeSciences investment community! 🎯Proud to support the #ESG Knowledge Project, a groundbreaking initiative shaping #Sustainability standards. buff.ly/4fUWC4i #VentureCapital

submitted 91 days ago • 0 comments

🎙️Nueva entrega de nuestro #Podcast? PÍLDORAS DE BIOTECH💊 🎯#Obesidad: la gran epidemia del siglo XXI.🔬Descubre cómo la #innovación farmacéutica está redefiniendo el futuro de la obesidad y sus tratamientos. ▶️https://spoti.fi/49ffici #YsiosPodcast #BiotechPillsWithJordi

submitted 92 days ago • 0 comments

#Speaker I Hoy nuestro #partner Raúl Martín-Ruiz estará en el #CongresoCIBER. 📣No te pierdad la mesa redonda sobre colaboración público-privada en el sector #biotech en #España. 🎙️CIBER, un aliado para el sector privado 👉https://bit.ly/49aRLJJ #techtransfer #invertirenciencia #vc

submitted 96 days ago • 0 comments

Gilead buys experimental HIV vaccines from small Barcelona biotech Aelix Therapeutics took its vaccines into Phase 2 in combination w/the California drugmaker's toll-like receptor agonist vesatolimod

submitted 98 days ago • 0 comments

#PortfolioNews I We're proud to share that we have joined the oversubscribed $135M Series B financing of our #portfolio company #Adcendo👏 🎯Developing breakthrough #ADCs, for the #treatment of underserved #cancers 👉Full details buff.ly/3Z3JfYm #vc #oncology #Innovation #biotech #Europe #investment

submitted 98 days ago • 0 comments

#PortfolioNews I Exciting news from AELIX Therapeutics! 🌍 Their HIV vaccine has been acquired by Gilead Sciences, a global leader in HIV research and innovation. 🔬 🎯 Committed to fostering the growth of the Spanish biotech ecosystem and driving positive societal impact. 👉 buff.ly/3OnAUtt

submitted 99 days ago • 0 comments

🚀 Our first #ESG report is here! 🎯Discover how Ysios Capital is driving #innovation, #sustainability, and #impact in #LifeSciences. 🌍 👉https://bit.ly/3OeHX7X #Report #vc #Biotech #Diversityandinclusion

submitted 104 days ago • 0 comments